The spatial pattern of the vacuolation in patients with sporadic Creutzfeldt-Jakob disease

Neuroscience Letters

Volumn 281, Issue 2-3, 2000, Pages 187-190

  Armstrong, R A ^a   Cairns, N J ^b   Lantos, P L ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b Brain Bank   (United Kingdom)

Author keywords

Cerebellum; Cerebral cortex; Clustering; Creutzfeldt Jakob disease; Hippocampus; Vacuoles

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN CORTEX; CELL VACUOLE; CEREBELLUM; CLINICAL ARTICLE; CREUTZFELDT JAKOB DISEASE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

AGED; BRAIN; CEREBELLUM; CEREBRAL CORTEX; CREUTZFELDT-JAKOB SYNDROME; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; PRIONS; VACUOLES;

EID: 0033998417     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00848-X     Document Type: Article

References (24)

1. Armstrong R.A. The usefulness of spatial pattern analysis in understanding the pathogenesis of neurodegenerative disorders, with special reference to plaque formation in Alzheimer's disease. Neurodegeneration. 2:1993;73-80.
2. Armstrong R.A. Analysis of spatial patterns in histological sections of brain tissue. J. Neurosci. Methods. 73:1997;141-147.
3. Betmouni S., Perry V.H., Gordon J.L. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience. 74:1996;1-5.
4. Betmouni S., Perry V.H. The acute inflammatory response in central nervous system following injection of prion brain homogenate or normal brain homogenate. Neuropathol. Appl. Neurobiol. 25:1999;20-28.
5. Budka H., Aguzzi A., Brown P., Brucher J.M., Bugiani O., Gullotta F., Haltia M., Hauw J.J., Ironside J.W., Jellinger K., Kretzschmar H.A., Lantos P.L., Masullo C., Schlote W., Tateishi J., Weller R.O. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (Prion diseases). Brain Pathol. 5:1995;459-466.
6. Castellani R., Parchi P., Stahl J., Capellari S., Cohen M., Gambetti P. Early pathological and biochemical changes in Creutzfeldt-Jakob disease: study of brain biopsies. Neurology. 46:1996;1690-1693.
7. Guentchev M., Hainfellner J.A., Trabattoni G.R., Budka H. Distribution of parvalbumin-immunoreactive neurons in brain correlates with hippocampal and temporal cortical pathology in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 56:1997;1119-1124.
8. Hiorns R.W., Neal J.W., Pearson R.C.A., Powell T.P.S. Clustering of ipsilateral cortico-cortical projection neurons to area 7 in the rhesus monkey. Proc. R. Soc. London. 246:1991;1-9.
9. Kovanen J. Clinical characteristics of familial and sporadic Creutzfeldt-Jakob disease in Finland. Acta Neurol. Scand. 87:1993;469-474.
10. Liou H.H., Jeng J.S., Chang Y.C., Chen R.C., Yip P.K. Is ataxic gait the predominant presenting manifestation of Creutzfeldt-Jakob disease? Experience of 14 Chinese cases from Taiwan. J. Neurol. Sci. 140:1996;53-60.
11. MacDonald S.T., Sutherland K., Ironside J.W. Prion protein genotype and pathological phenotype studies in sporadic Creutzfeldt-Jakob disease. Neuropathol. Appl. Neurobiol. 22:1996;285-292.
12. Masters C.L., Richardson E.P. Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease): the nature and progression of spongiform change. Brain. 101:1978;333-344.
13. Masullo C., Macchi G. Resistance of the hippocampus in Creutzfeldt-Jakob disease. Clin. Neuropathol. 16:1997;37-44.
14. Mizutani T. Neuropathology of Creutzfeldt-Jakob disease in Japan: with special reference to the panencephalopathic type. Acta Pathol. Jpn. 31:1981;903-922.
15. Muhleisen H., Gehrmann J., Meyermann R. Reactive microglia in Creutzfeldt-Jakob disease. Neuropathol. Appl. Neurobiol. 21:1995;505-517.
16. Russelakis-Carneiro M., Betmouni S., Perry V.H. Inflammatory response and retinal cell degeneration following intraocular injection of ME7. Neuropathol. Appl. Neurobiol. 25:1999;196-206.
17. Sasaki A., Hirato J., Nakajato Y. Immunohistochemical study of microglia in the Creutzfeldt-Jakob diseased brain. Acta Neuropathol. 86:1993;337-344.
18. Schulz-Schaeffer W.J., Giese A., Windl O., Kretschmar H.A. Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease. Clin. Neuropathol. 15:1996;353-357.
19. von Eitzen U., Egerosperger R., Kosel S., Graston-Frodl E.M., Imai Y., Bise K., Kohsaka S., Mehraein P., Graeber M.B. Microglia and the development of spongiform change in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 57:1998;246-256.
20. Walis A., Liberski P.P., Brown P., Gajdusek D.C. Electron microscope studies of the optic nerve in experimental scrapie and the panencephalopathic type of Creutzfeldt-Jakob disease. Folia Neuropathol. 35:1997;255-258.
21. Watanabe R., Duchen L.W. Cerebral amyloid in human prion disease. Neuropathol. Appl. Neurobiol. 19:1993;253-260.
22. Will R.G., Mathews W.B. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. 1. Clinical features. J. Neurol. Neurosurg. Psychiatr. 47:1984;134-140.
23. Will R.G., Alperovitch A., Poser S., Pocchiari M., Hofman A., Mitrova E., deSilva R., Dalessandro M., Delasnerie-Laupretre N., Zerr I., van Duijn C. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries 1993-1995. Ann. Neurol. 43:1998;763-767.
24. Williams A.E., Lawson L.J., Perry V.H., Fraser H. Characterization of the microglial response in murine scrapie. Neuropathol. Appl. Neurobiol. 20:1994;47-55.